Could permanent dialysis access replace catheters in ICU kidney therapy?

NCT ID NCT07447128

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether using a patient's permanent dialysis access (a fistula or graft) instead of a temporary catheter is safe and effective for delivering continuous kidney replacement therapy in the ICU. Researchers will enroll 50 adults with end-stage kidney disease who are in the ICU and need this therapy. The goal is to develop a standard procedure and see if the access stays usable without complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Cannulation of permanent dialysis access (arteriovenous fistula or graft) for continuous renal replacement therapy

What this could lead to

If successful, this could lead to a safer, standard way to deliver continuous kidney therapy in the ICU, reducing infections and blood vessel damage from repeated catheter use.

What could go wrong

This is a small, early feasibility study with only 50 participants, so results may not apply broadly. The procedure requires highly trained staff and may not be practical in all ICU settings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • East Carolina University Medical Center

    Greenville, North Carolina, 27834, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••